Cite Filings / KTTA / 0001493152-22-025132
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Pasithea Therapeutics Corp. · Filed 2022-09-06 · Acc 0001493152-22-025132

Documents 1

  • SC 13D/A Beneficial Ownership Report , formsc13da.htm

Around this filing

  • 2022-11-01 SC 13D/A Beneficial Ownership Report
  • 2022-09-06 SC 13D/A Beneficial Ownership Report
  • 2022-09-06 DFAN14A Proxy Soliciting Materials
  • 2022-09-06 4 Member of 10% owner group bought 88,901 shares at an average $1.13 ($100,367)
  • 2022-09-01 SC 13D/A Beneficial Ownership Report
  • 2022-08-31 4 Member of 10% owner group bought 22,828 shares at an average $1.15 ($26,293)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Stonepine Capital Management, LLC 8.3%
  2. 2026-11-16 SCHEDULE 13G/A · Vivo Opportunity Fund Holdings, L.P. 9.99%
  3. 2026-11-16 SCHEDULE 13G/A · Ameriprise Financial, Inc. 4.1%
Loading formsc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…